Rocket Lab Just Gained 13% in a Week: Take Profits, or Buy More? Wiltone Asuncion Tue, November 10, 2026 at 8:27 AM EST 4 min read RKLB -9.45% SPCX -3.20% ^GSPC +2.35% FLY -4.36% Explore stocks on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Rocket Lab gained 13% in the past week with no news of its own, while the S&P 500 finished flat.
It fell harder than SpaceX in Thursday's AI-led sell-off, rebounded Friday, and rallied again Monday after NASA named rivals such as Firefly Aerospace to its new moon program.
Analysts expect revenue to more than double from 2025 to 2027, but the stock still trades above its usual sales multiple.
Third-quarter revenue hit a record, but Neutron's first flight still has no date, and the stock needs one before it's worth buying.
Rocket Lab (RKLB:NASDAQ) gained 13% in the past week without a word of news from the company.
It traded with the rest of space instead, falling harder than SpaceX (SPCX:NASDAQ) in Thursday's AI-led sell-off and bouncing back on Friday. Then on Monday it jumped ahead of its third-quarter report as space stocks rallied after NASA named eight companies eligible to compete for its CLPS 2 lunar delivery program, worth up to $10 billion. The list included rival Firefly Aerospace (FLY:NASDAQ) and left out Rocket Lab.
SpaceX's AI compute business brought in more than half of its third-quarter revenue. Rocket Lab doesn't have one. And Monday's rally rode on a NASA program Rocket Lab isn't part of. Firefly also signed a deal worth more than $1.3 billion to supply engines for AST SpaceMobile's Blacklift rocket. It's also developing Eclipse, a medium-lift rocket built with Northrop Grumman that will compete with Neutron, so every contract Firefly wins raises the stakes.
TIKR tracks 22 analysts on Rocket Lab. How many say "Buy"?
See the full breakdown of Buy, Hold, and Sell ratings on Rocket Lab, along with Wall Street's revenue and earnings estimates, all in one place. More than 500,000 investors use TIKR to research stocks like this one. See Rocket Lab's Analyst Ratings
After Monday's close, Rocket Lab reported record third-quarter revenue of $268 million, above its $250 million to $265 million guide, and an adjusted EBITDA loss of $18 million, inside its guided range. But its 12-cent loss per share missed the 7-cent estimate, and the stock slipped after hours. Analysts expect revenue to keep climbing from there:
That's $1.33 billion in 2027, more than double 2025's $602 million. Neutron is the bigger question. Its first flight slipped into 2027 in mid-October after air pockets turned up in a first-stage tank dome. CEO Peter Beck still won't give a launch date until the tank passes all its tests. CFO Adam Spice said Rocket Lab expects "negative non-GAAP free cash flow in the fourth quarter to remain at elevated levels." It had about $4.7 billion of cash and securities at Sept. 30.
Rocket Lab is 61% below its May 27 record close of $150.23 and still isn't cheap, at 28x forward sales on Friday against a five-year average of 21x:
After Monday's jump, it's higher still. The $102 consensus target sits about 74% above Monday's $58.86 close, but that upside depends on Neutron flying on time.
If you own it, a week of sector swings is no reason to sell a business that just grew revenue 73%. Buying more makes sense once Rocket Lab puts a quarter on Neutron's first flight. A firm date in the first half of 2027 would make the Street's targets look a lot more reasonable.
TIKR lets you forecast the future price of any stock in less than a minute. Just enter a few assumptions into TIKR's valuation model and see what Rocket Lab could be worth. Start from Wall Street consensus estimates, or adjust the inputs to reflect your own view of the business. It's free to use.